- Published on
Infectious disease and microbiology – Nocardiosis
Nocardiosis is an invasive opportunistic infection caused by Nocardia species, a group of aerobic, Gram-positive, branching filamentous bacteria belonging to the order Actinomycetales. First described in 1889, the disease may present as localized or disseminated infection, most commonly involving the lungs, but it can spread hematogenously—especially to the central nervous system (CNS)—and virtually any organ, including the skin, heart, kidneys, bones, and soft tissues.
Clinical manifestations range from pulmonary disease (acute, chronic, or subclinical) to brain abscesses, cellulitis, lymphocutaneous disease, actinomycetoma, and keratitis.
The infection is typically acquired through inhalation of organisms from soil or organic matter, making the lungs the primary site of infection, although traumatic skin inoculation or mucosal entry can also occur. There is no significant person-to-person transmission. Approximately 1,000 cases occur annually in the United States, with most involving pulmonary or systemic disease. Although nocardiosis can affect individuals of any age, it is more common in adults and males, and while many patients are immunocompromised, up to one-third are immunocompetent.
Major risk factors include conditions that impair cell-mediated immunity, such as HIV/AIDS, malignancy, organ transplantation, corticosteroid or TNF-alpha inhibitor therapy, Cushing’s syndrome, and chronic granulomatous disease. The most common pathogen is Nocardia asteroides, though other species like N. brasiliensis are associated with cutaneous disease, particularly in tropical regions.
Clinically, nocardiosis presents with nonspecific symptoms, especially in pulmonary disease, including productive cough, fever, weight loss, malaise, and occasionally dyspnea or hemoptysis. The disease may follow a chronic or relapsing course, and dissemination—particularly to the brain—may initially be asymptomatic. Cutaneous forms present as cellulitis, nodules, ulcers, or lymphocutaneous spread, while actinomycetoma causes chronic, deforming lesions with draining sinuses. CNS involvement typically manifests as brain abscesses, which are often multiple and indolent.
Diagnosis relies on microscopic and microbiological identification. Specimens such as sputum or pus reveal branching, beaded Gram-positive filaments, often requiring modified acid-fast staining. Cultures grow slowly and may take up to several weeks, forming chalky, pigmented colonies with a characteristic odor. Imaging studies such as chest X-ray or CT may show nodules, cavitations, or infiltrates, while brain imaging (CT/MRI) is essential when CNS involvement is suspected.
Treatment is prolonged and often requires combination antimicrobial therapy. First-line treatment includes trimethoprim-sulfamethoxazole (TMP-SMX), with alternatives such as amikacin, imipenem, ceftriaxone, or minocycline, depending on disease severity and susceptibility patterns. Therapy duration is typically 6–12 months, longer for CNS or immunocompromised cases. Surgical drainage or excision may be necessary for large abscesses or extensive disease.
Close follow-up is essential due to the risk of relapse or dissemination, even after apparent clinical improvement. Prognosis depends on immune status and extent of disease; mortality is relatively low in immunocompetent patients with localized pulmonary disease (~15%) but significantly higher in disseminated or CNS infections. Complications include brain abscess rupture, spinal cord compression, empyema, fistula formation, and widespread organ involvement, highlighting the need for early diagnosis and aggressive management.
Nocardiosis is an invasive opportunistic infection caused by Nocardia species, a group of aerobic, Gram-positive, branching filamentous bacteria belonging to the order Actinomycetales. First described in 1889, the disease may present as localized or disseminated infection, most commonly involving the lungs, but it can spread hematogenously—especially to the central nervous system (CNS)—and virtually any organ, including the skin, heart, kidneys, bones, and soft tissues.
Clinical manifestations range from pulmonary disease (acute, chronic, or subclinical) to brain abscesses, cellulitis, lymphocutaneous disease, actinomycetoma, and keratitis.
The infection is typically acquired through inhalation of organisms from soil or organic matter, making the lungs the primary site of infection, although traumatic skin inoculation or mucosal entry can also occur. There is no significant person-to-person transmission. Approximately 1,000 cases occur annually in the United States, with most involving pulmonary or systemic disease. Although nocardiosis can affect individuals of any age, it is more common in adults and males, and while many patients are immunocompromised, up to one-third are immunocompetent.
Major risk factors include conditions that impair cell-mediated immunity, such as HIV/AIDS, malignancy, organ transplantation, corticosteroid or TNF-alpha inhibitor therapy, Cushing’s syndrome, and chronic granulomatous disease. The most common pathogen is Nocardia asteroides, though other species like N. brasiliensis are associated with cutaneous disease, particularly in tropical regions.
Clinically, nocardiosis presents with nonspecific symptoms, especially in pulmonary disease, including productive cough, fever, weight loss, malaise, and occasionally dyspnea or hemoptysis. The disease may follow a chronic or relapsing course, and dissemination—particularly to the brain—may initially be asymptomatic. Cutaneous forms present as cellulitis, nodules, ulcers, or lymphocutaneous spread, while actinomycetoma causes chronic, deforming lesions with draining sinuses. CNS involvement typically manifests as brain abscesses, which are often multiple and indolent.
Diagnosis relies on microscopic and microbiological identification. Specimens such as sputum or pus reveal branching, beaded Gram-positive filaments, often requiring modified acid-fast staining. Cultures grow slowly and may take up to several weeks, forming chalky, pigmented colonies with a characteristic odor. Imaging studies such as chest X-ray or CT may show nodules, cavitations, or infiltrates, while brain imaging (CT/MRI) is essential when CNS involvement is suspected.
Treatment is prolonged and often requires combination antimicrobial therapy. First-line treatment includes trimethoprim-sulfamethoxazole (TMP-SMX), with alternatives such as amikacin, imipenem, ceftriaxone, or minocycline, depending on disease severity and susceptibility patterns. Therapy duration is typically 6–12 months, longer for CNS or immunocompromised cases. Surgical drainage or excision may be necessary for large abscesses or extensive disease.
Close follow-up is essential due to the risk of relapse or dissemination, even after apparent clinical improvement. Prognosis depends on immune status and extent of disease; mortality is relatively low in immunocompetent patients with localized pulmonary disease (~15%) but significantly higher in disseminated or CNS infections. Complications include brain abscess rupture, spinal cord compression, empyema, fistula formation, and widespread organ involvement, highlighting the need for early diagnosis and aggressive management.
0 Comments
